Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer
Stopped Protocol modification
Conditions
- Male Breast Cancer
- Recurrent Breast Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage IIIC Breast Cancer
Interventions
- DRUG: lapatinib ditosylate
- RADIATION: radiation therapy
- OTHER: laboratory biomarker analysis
Sponsor
Stanford University
Collaborators